A detailed history of Xy Capital LTD transactions in Zai Lab LTD stock. As of the latest transaction made, Xy Capital LTD holds 305,397 shares of ZLAB stock, worth $9.47 Million. This represents 3.13% of its overall portfolio holdings.

Number of Shares
305,397
Holding current value
$9.47 Million
% of portfolio
3.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$24.29 - $38.35 $7.42 Million - $11.7 Million
305,397 New
305,397 $11 Billion
Q3 2023

Nov 01, 2023

BUY
$22.72 - $31.49 $3.17 Million - $4.4 Million
139,743 New
139,743 $3.4 Billion
Q1 2023

May 08, 2023

SELL
$30.21 - $48.1 $64,045 - $101,972
-2,120 Reduced 11.82%
15,820 $526 Million
Q4 2022

Feb 09, 2023

BUY
$22.28 - $38.71 $399,703 - $694,457
17,940 New
17,940 $551 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.04B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Xy Capital LTD Portfolio

Follow Xy Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xy Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xy Capital LTD with notifications on news.